Comparative pharmacokinetics and tissue penetration of sulbactam and ampicillin after concurrent intravenous administration.
about
Comparison of concentrations of sulbactam-ampicillin administered by bolus injections or bolus plus continuous infusion in tissues of patients undergoing colorectal surgery.Comparison of ampicillin-sulbactam regimens simulating 1.5- and 3.0-gram doses to humans in treatment of Escherichia coli bacteremia in mice.Drug concentrations in the serum and cerebrospinal fluid of patients treated with cefoperazone/sulbactam after craniotomyPharmacokinetics of cefoperazone (2.0 g) and sulbactam (1.0 g) coadministered to subjects with normal renal function, patients with decreased renal function, and patients with end-stage renal disease on hemodialysis.Multiple-dose pharmacokinetics of intravenously administered cefoperazone and sulbactam when given in combination to infected, seriously ill, elderly patients.Pharmacokinetics of ampicillin (2.0 grams) and sulbactam (1.0 gram) coadministered to subjects with normal and abnormal renal function and with end-stage renal disease on hemodialysis.Penetration of sulbactam and ampicillin into cerebrospinal fluid of infants and young children with meningitisPenetration of sulbactam-ampicillin and clavulanic acid-amoxicillin into the pelvic peritoneum.Comparative activities of the beta-lactamase inhibitors YTR 830, clavulanate, and sulbactam combined with ampicillin and broad-spectrum penicillins against defined beta-lactamase-producing aerobic gram-negative bacilli.Pharmacokinetics of sultamicillin in mice, rats, and dogsSerum and blister fluid pharmacokinetics and bactericidal activities of ampicillin-sulbactam, cefotetan, cefoxitin, ceftizoxime, and ticarcillin-clavulanate.Proposed changes in interpretive criteria and potency of ampicillin and ampicillin-sulbactam disks for susceptibility tests.Optimal dilution susceptibility testing conditions, recommendations for MIC interpretation, and quality control guidelines for the ampicillin-sulbactam combinationMultiple-dose pharmacokinetics and toleration of intravenously administered cefoperazone and sulbactam when given as single agents or in combination.Pharmacokinetics and pharmacodynamics of cefoperazone-sulbactam in patients on continuous ambulatory peritoneal dialysis.New sensitive bioassay for sulbactam in bovine tissues.Penetration of sulbactam and ampicillin into peritoneal fluid.Pharmacokinetics of sulbactam in humans.Pharmacokinetics of cefoperazone and sulbactam in liver transplant patients.
P2860
Q33695230-6D35A32E-AB57-40DF-8B6A-B90060234366Q35113629-D12E9BC9-FF04-4D69-BAC1-E08672045A84Q35205195-80851559-E949-40B5-8E81-A98A67BC2D81Q35299177-B31E38A5-EC6C-48B2-9E26-DF7BBC4DFB1CQ35305116-15808E58-15A0-45F7-9A98-1257176CBA7FQ35347789-D91A2D3D-E902-4DEF-BDA3-A4745556ACE1Q35543154-03CA84E0-C9C4-44E9-BA3F-3F23D49CEE20Q35572072-0E21401C-25BB-406F-938E-BBE84C205AFEQ35650267-635FF729-8CE9-4DFA-9961-A5502E8FBE52Q35759894-700FEC04-1BAA-4987-B23F-32630B236C91Q36757852-C5ACE010-AF5C-4D1D-80AA-96BF93D61537Q37147810-3E621C17-FD7E-482D-A853-AA733A34BD72Q37220644-E4CF4827-4EDD-49D0-A873-134C350B0961Q39817465-54361B4F-A0BC-4F1E-98B2-35E4CCAB4C32Q39817477-5819E617-7E83-45EA-ABC8-89897DCDEEFCQ39832272-9600F355-99D0-44EC-9690-696C96AB98F8Q42030800-48361D1C-8145-4025-BC91-5E7F43A41EA4Q42928624-A0C26C7F-582F-4655-8912-C8C78B74AC41Q44013965-F0A5BF58-FAE7-416B-9491-986AF8F01A9D
P2860
Comparative pharmacokinetics and tissue penetration of sulbactam and ampicillin after concurrent intravenous administration.
description
1982 nî lūn-bûn
@nan
1982年の論文
@ja
1982年論文
@yue
1982年論文
@zh-hant
1982年論文
@zh-hk
1982年論文
@zh-mo
1982年論文
@zh-tw
1982年论文
@wuu
1982年论文
@zh
1982年论文
@zh-cn
name
Comparative pharmacokinetics a ...... nt intravenous administration.
@en
Comparative pharmacokinetics a ...... nt intravenous administration.
@nl
type
label
Comparative pharmacokinetics a ...... nt intravenous administration.
@en
Comparative pharmacokinetics a ...... nt intravenous administration.
@nl
prefLabel
Comparative pharmacokinetics a ...... nt intravenous administration.
@en
Comparative pharmacokinetics a ...... nt intravenous administration.
@nl
P2093
P2860
P356
P1476
Comparative pharmacokinetics a ...... nt intravenous administration.
@en
P2093
P2860
P304
P356
10.1128/AAC.21.4.565
P407
P577
1982-04-01T00:00:00Z